Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TMEM205 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
mRNA | PLEKHF2 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
mRNA | GYPA | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
mRNA | MYH9 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
mRNA | TBX15 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
mRNA | NLRC3 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.02 |
mRNA | COQ6 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
mRNA | NAB1 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
mRNA | INO80E | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
mRNA | MIDN | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |